These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32993820)

  • 21. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
    Adams DJ; Barone JB; Nylund CM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital.
    Khanafer N; Vanhems P; Bennia S; Martin-Gaujard G; Juillard L; Rimmelé T; Argaud L; Martin O; Huriaux L; Marcotte G; Hernu R; Floccard B; Cassier P; Group S
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299978
    [No Abstract]   [Full Text] [Related]  

  • 23. Association between prevalence of laboratory-identified
    Xu K; Wu H; Li Q; Edwards JR; O'Leary EN; Leaptrot D; Benin AL
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1847-1852. PubMed ID: 35068404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital-level high-risk antibiotic use in relation to hospital-associated
    Tabak YP; Srinivasan A; Yu KC; Kurtz SG; Gupta V; Gelone S; Scoble PJ; McDonald LC
    Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1229-1235. PubMed ID: 31522695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection.
    Durkin MJ; Baker AW; Dicks KV; Lewis SS; Chen LF; Anderson DJ; Sexton DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2015 Feb; 36(2):125-31. PubMed ID: 25632994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Pisapia R; Gärtner B; Berger FK; Reigadas E; Bouza E; Demont C; Wilcox MH
    Anaerobe; 2020 Apr; 62():102178. PubMed ID: 32092415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the association of room features with healthcare-facility-onset
    Root ED; Lindstrom M; Xie A; Mangino JE; Moffatt-Bruce S; Hebert C
    Infect Control Hosp Epidemiol; 2021 Jul; 42(7):847-852. PubMed ID: 33261688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital-acquired
    Vader DT; Weldie C; Welles SL; Kutzler MA; Goldstein ND
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):948-954. PubMed ID: 33280624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residual effect of community antimicrobial exposure on risk of hospital onset healthcare-associated Clostridioides difficile infection: a case-control study using national linked data.
    Pan J; Kavanagh K; Marwick C; Davey P; Wuiff C; Bryson S; Robertson C; Bennie M
    J Hosp Infect; 2019 Nov; 103(3):259-267. PubMed ID: 31173780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.
    Baggs J; Yousey-Hindes K; Ashley ED; Meek J; Dumyati G; Cohen J; Wise ME; McDonald LC; Lessa FC
    Vaccine; 2015 Nov; 33(46):6241-9. PubMed ID: 26450660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between hospital-onset and community-onset Clostridioides difficile infection incidence: Ward-level analysis following hospital relocation.
    Shiode J; Fujii M; Nasu J; Itoh M; Ishiyama S; Fujiwara A; Yoshioka M
    Am J Infect Control; 2022 Nov; 50(11):1240-1245. PubMed ID: 35167897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center.
    Hostler CJ; Bertumen JB; Park LP; Wilkins SB; Woods CW
    Am J Infect Control; 2020 Oct; 48(10):1148-1151. PubMed ID: 31911067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network.
    Turner NA; Grambow SC; Woods CW; Fowler VG; Moehring RW; Anderson DJ; Lewis SS
    JAMA Netw Open; 2019 Oct; 2(10):e1914149. PubMed ID: 31664443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network's laboratory-identified event reporting module versus clinical infection surveillance.
    Gase KA; Haley VB; Xiong K; Van Antwerpen C; Stricof RL
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):284-90. PubMed ID: 23388363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.
    Bertolino L; Patauner F; Gagliardi M; D'Amico F; Crivaro V; Bernardo M; Scherillo I; Bellitti F; Cusano C; Greco R; Panetta V; Durante A; Di Caterino A; Frieri A; Cioffi G; Nappo M; Corrado M; Lanzieri M; Sabatini P; Bettelli R; Dello Russo R; Taddeo ML; Petrone R; Di Sevo MG; Iannuzzo M; Iervolino M; Buonocore R; D'Agostino F; Gambardella M; De Martino A; Spagnuolo S; Savarese M; Sole S; Russo C; Agozzino E; Galdiero M; Martino R; Calemma R; Sciambra A; Aprea C; Colaccio D; Di Guida P; Venditti M; Montella E; Guerriero F; Perrotta R; Di Filippo U; Pizza A; Di Fronzo A; Lombardi A; Capuano L; De Stefano A; Mastropietro A; Mastro M; Loffreda R; Maccarone L; Di Tora A; Oto S; Tammaro C; Mondelli AC; Ruocco M; Ferraro B; Petrosino A; Presta SSA; Durante Mangoni E
    Infez Med; 2021 Mar; 29(1):70-78. PubMed ID: 33664175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
    Schechner V; Fallach N; Braun T; Temkin E; Carmeli Y
    J Antimicrob Chemother; 2021 Jul; 76(8):2182-2185. PubMed ID: 33969419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Economic Burden of
    Braae UC; Møller FT; Ibsen R; Ethelberg S; Kjellberg J; Mølbak K
    Front Public Health; 2020; 8():562957. PubMed ID: 33324595
    [No Abstract]   [Full Text] [Related]  

  • 39. Costs Associated with the Treatment of Clostridioides Difficile Infections.
    Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.
    Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM
    Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.